Galapagos recruiting efforts going strong

An enormous banner adorns the third and fourth floor windows of the office building in Leiden: Galapagos is hiring experts in drug development.

Last November, Galapagos launched a major recruiting drive under the slogan ‘Think Big’. Some fifty people have since started in newly created positions within the company. But even this influx of big thinkers is not enough to ensure we achieve our ambitions. We aim to attract a further fifty new staff members before the end of this year.

‘At present we are focusing on development jobs – the people needed to take a new medicine all the way from test tube to market,’ explains Veronique Deiteren, Head of Human Resources. ‘But eventually, our medicines will also have to be brought to the attention of potential buyers. Over the next few years we will look for experts in sales and marketing as well. Attracting the right person for every job is an important part of realizing our overall goal: becoming Europe’s largest, most successful biotech, and delivering our own medicines to the market in order to improve people’s lives.’

All current vacancies are listed on the website. All jobs in development can be carried out from any of the locations in the Netherlands, Belgium and France. They include opportunities in clinical operations, medical development, regulatory affairs, quality monitoring and project management. ‘We are looking for experienced and ambitious people who are ready to take the next step in their career, keen to work in a very dynamic setting.’

‘Galapagos combines excellent science with strong commerce. The lines are short and you will see the direct impact of your work. Development is extremely rapid; change is a constant. We are looking for the type of person who thrives in this environment. You could say that we combine the relative security of working in the pharmaceutical industry with all the excitement and challenge of a career in a biotech company – a very successful biotech company. If this appeals to you, get in touch and let’s talk.’

18 September 2017